Correlation Between Anebulo Pharmaceuticals and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Akari Therapeutics PLC, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Akari Therapeutics.
Diversification Opportunities for Anebulo Pharmaceuticals and Akari Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Anebulo and Akari is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Akari Therapeutics
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 1.29 times more return on investment than Akari Therapeutics. However, Anebulo Pharmaceuticals is 1.29 times more volatile than Akari Therapeutics PLC. It trades about -0.01 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.23 per unit of risk. If you would invest 183.00 in Anebulo Pharmaceuticals on August 29, 2024 and sell it today you would lose (43.00) from holding Anebulo Pharmaceuticals or give up 23.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 98.44% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Akari Therapeutics PLC |
Anebulo Pharmaceuticals and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Akari Therapeutics
The main advantage of trading using opposite Anebulo Pharmaceuticals and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Anebulo Pharmaceuticals vs. Valneva SE ADR | Anebulo Pharmaceuticals vs. Bright Minds Biosciences | Anebulo Pharmaceuticals vs. HP Inc | Anebulo Pharmaceuticals vs. Intel |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |